PHAXIAM THERAPEUTICS (PHXM): key financial figures for fiscal year 2023 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2023)
- €1.3M
- Net Income/Loss (FY2023)
- -€23.5M
- Total Assets (FY2023)
- €51.3M
- Total Equity (FY2023)
- €25.6M
- Cash Flows from Operating Activities (FY2023)
- -€24.4M
Source: PHAXIAM THERAPEUTICS annual_report filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
